Abnormality of thrombocytes, Acrocyanosis, Acute leukemia, Acute myeloid leukemia, Amaurosis fugax, Anemia, Angina pectoris, Anorexia, Arterial thrombosis, Arthralgia, Bone marrow hypercellularity, Bruising susceptibility, Budd-Chiari syndrome, Cachexia, Cerebral hemorrhage, Cerebral ischemia, Chest pain, Chronic myelogenous leukemia, Constitutional symptom, Cough, Dysarthria, Dyspnea, Easy fatigability, Ecchymosis, Eczema, Epistaxis, Exertional dyspnea, Extramedullary hematopoiesis, Fatigue, Fever, Flank pain, Gastrointestinal hemorrhage, Gingival bleeding, Headache, Hemangioma, Hematological neoplasm, Hepatomegaly, Hepatosplenomegaly, Hyperhidrosis, Hypertension, Impaired platelet aggregation, Increased circulating lactate dehydrogenase concentration, Increased hematocrit, Increased hemoglobin, Increased megakaryocyte count, Increased red blood cell mass, Intermittent claudication, Leukocytosis, Low-grade fever, Lymphadenopathy, Miscarriage, Myelodysplasia, Myelofibrosis, Myeloproliferative disorder, Myocardial infarction, Pallor, Pancytopenia, Paresthesia, Peripheral arterial stenosis, Peripheral thrombosis, Petechiae, Plethora, Poikilocytosis, Polycythemia, Portal hypertension, Portal vein thrombosis, Prolonged bleeding time, Pruritus, Pulmonary arterial hypertension, Pulmonary embolism, Purpura, Respiratory insufficiency, Seizure, Splenomegaly, Stroke, Syncope, Thrombocytopenia, Thrombocytosis, Thromboembolism, Tinnitus, Transient ischemic attack, Venous thrombosis, Vertigo, Visual field defect, Weight loss

abnormal hematopoietic system physiology, abnormal mammary gland development, abnormal mammary gland growth during lactation, abnormal mammary gland growth during pregnancy, abnormal megakaryocyte differentiation, abnormal megakaryocyte morphology, abnormal myelopoiesis, abnormal spleen red pulp morphology, abnormal spleen white pulp morphology, abnormal thrombosis, absent common myeloid progenitor cells, decreased bone marrow cell number, decreased circulating iron level, decreased embryo size, decreased erythroblast number, decreased erythrocyte cell number, decreased hematocrit, decreased hematopoietic stem cell number, decreased hemoglobin content, decreased mean corpuscular volume, decreased spleen white pulp amount, embryonic lethality during organogenesis, complete penetrance, embryonic lethality, complete penetrance, enhanced megakaryocyte emperipolesis, hematopoietic system phenotype, impaired hematopoiesis, increased compact bone thickness, increased erythrocyte cell number, increased granulocyte number, increased hematopoietic stem cell number, increased hemolymphoid system tumor incidence, increased megakaryocyte progenitor cell number, increased neutrophil cell number, increased number of Howell-Jolly bodies, increased spleen red pulp amount, increased spleen weight, lactation failure, lethality throughout fetal growth and development, complete penetrance, limb paralysis, microcytosis, myeloid hyperplasia, no abnormal phenotype detected, polychromatophilia, premature death, prenatal lethality, complete penetrance, small liver, spleen fibrosis